These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 804311)

  • 21. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 22. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 23. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
    Rizzi G; Isaia GC
    Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
    [No Abstract]   [Full Text] [Related]  

  • 24. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mode of action of oral antidiabetic drugs].
    Frey H
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics.
    Geisen K; Hitzel V; Okomonopoulos R; Pünter J; Weyer R; Summ HD
    Arzneimittelforschung; 1985; 35(4):707-12. PubMed ID: 3925960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J; Cordes U; Krall H; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract]   [Full Text] [Related]  

  • 28. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of biguanides and sulfonylureas on insulin receptors in cultured cells.
    Goldfine ID; Iwamoto Y; Pezzino V; Trischitta V; Purrello F; Vigneri R
    Diabetes Care; 1984; 7 Suppl 1():54-8. PubMed ID: 6734405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
    Srivastava PP; Murthy PS; Mukherjee SK
    Indian J Exp Biol; 1983 Jul; 21(7):390-2. PubMed ID: 6365752
    [No Abstract]   [Full Text] [Related]  

  • 31. [Synergism between oral diabetics and insulin].
    Consiglio D; Mantia G; Hopps V
    Boll Soc Ital Biol Sper; 1971 Nov; 47(22):737-42. PubMed ID: 5004485
    [No Abstract]   [Full Text] [Related]  

  • 32. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
    Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
    [No Abstract]   [Full Text] [Related]  

  • 34. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J; Cordes U; Sell G; Krall H; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract]   [Full Text] [Related]  

  • 35. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of high concentrations of glucose on thrombocyte aggregation].
    Lisovskaia IL; Volkova RI; Markosian RA
    Biull Eksp Biol Med; 1974 Oct; 78(10):24-7. PubMed ID: 4461114
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative activity of some biguanides, sulfonylureas and their combinations on blood sugar and lactic acid in the guinea pig. II].
    Bramanti G; Bianchini P; De Fina V; Dell'Omodarme G
    Boll Chim Farm; 1971 Apr; 110(4):226-36. PubMed ID: 5111348
    [No Abstract]   [Full Text] [Related]  

  • 38. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 39. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
    Haupt E; Beyer J; Schöffling K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
    [No Abstract]   [Full Text] [Related]  

  • 40. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
    Balant L
    Diabete Metab; 1978 Jun; 4(2):135-43. PubMed ID: 98364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.